It's been about three decades since the heyday of Michael Milken's Drexel Burnham Lambert. It all came crashing down, but his legacy lives on in the high-yield market, in such firms as Moelis & Co. and at the Milken Institute, a think tank whose global conference starts Sunday in Los Angeles. A reunion
See Original Article

Proponents of science-based medicine are fond of saying that there's a name for alternative treatments that pass scientific tests: medicine. But what they don't mention are those parts of long-established medicine that get demoted to “alternative” status — or should be. For years, doctors pestered me
See Original Article

Last November, the Bank of England raised interest rates for the first time in a decade and then warned there could be more increases to come. The economy was faring better than expected after the Brexit vote. Inflation was well above the bank's 2 percent target, after the depreciation of sterling had
See Original Article

Bill Faries, Bloomberg News national security team leader, discusses the Friday meeting between North Korean leader Kim Jong Un and South Korean president Moon Jae-in in a historic summit on the border between their two countries. Kim and Moon agreed to work towards a peace agreement to
See Original Article

He's a billionaire. He's been compared to a superhero. And he's invested in electric cars. And no, he's not “Iron Man” Elon Musk. Illustration: Kagan McLeod for Bloomberg Markets. If you're looking for more reinforcement that electric cars are here to stay, look no further than Asia's fifth-richest man,
See Original Article